Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5,10-DIHYDRO-PHENAZINE, with the molecular formula C12H10N2, is a bicyclic aromatic compound characterized by its phenazine core. It is a versatile chemical entity that occurs naturally in various products and is also synthesized for use in pharmaceuticals. Known for its biological activities, such as anti-tumor and antimicrobial properties, 5,10-DIHYDRO-PHENAZINE has garnered interest for its potential therapeutic applications in treating cancer and bacterial infections. Its unique structure and reactivity also make it a candidate for organic synthesis and material science, highlighting its significance across medicine, biology, and materials science.

613-32-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 613-32-1 Structure
  • Basic information

    1. Product Name: 5,10-DIHYDRO-PHENAZINE
    2. Synonyms: AURORA KA-4601;5,10-DIHYDRO-PHENAZINE;Phenazine,5,10-dihydro-
    3. CAS NO:613-32-1
    4. Molecular Formula: C12H10N2
    5. Molecular Weight: 182.22
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 613-32-1.mol
  • Chemical Properties

    1. Melting Point: 315-316 °C
    2. Boiling Point: 358.5 °C at 760 mmHg
    3. Flash Point: 236.2 °C
    4. Appearance: /
    5. Density: 1.152 g/cm3
    6. Vapor Pressure: 2.54E-05mmHg at 25°C
    7. Refractive Index: 1.624
    8. Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
    9. Solubility: N/A
    10. PKA: 6.42±0.20(Predicted)
    11. CAS DataBase Reference: 5,10-DIHYDRO-PHENAZINE(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5,10-DIHYDRO-PHENAZINE(613-32-1)
    13. EPA Substance Registry System: 5,10-DIHYDRO-PHENAZINE(613-32-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 613-32-1(Hazardous Substances Data)

613-32-1 Usage

Uses

Used in Pharmaceutical Industry:
5,10-DIHYDRO-PHENAZINE is used as a therapeutic agent for its anti-tumor properties, targeting the treatment of various types of cancer. Its potential to combat bacterial infections also positions it as an antimicrobial agent.
Used in Organic Synthesis:
5,10-DIHYDRO-PHENAZINE is utilized as a key intermediate in the synthesis of other organic compounds, leveraging its reactivity and unique structure to form novel molecules with specific applications.
Used in Material Science:
5,10-DIHYDRO-PHENAZINE is employed in the development of new materials, where its chemical properties contribute to the creation of innovative substances with specialized uses in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 613-32-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 613-32:
(5*6)+(4*1)+(3*3)+(2*3)+(1*2)=51
51 % 10 = 1
So 613-32-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H10N2/c1-2-6-10-9(5-1)13-11-7-3-4-8-12(11)14-10/h1-8,13-14H

613-32-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,10-dihydrophenazine

1.2 Other means of identification

Product number -
Other names dihydrophenazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:613-32-1 SDS

613-32-1Synthetic route

Phenazin
92-82-0

Phenazin

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With sodium dithionite; water In ethanol for 2.5h; Ambient temperature;98%
With sodium dithionite In ethanol; water at 20℃; for 4h; Inert atmosphere;98%
With sodium dithionite In ethanol; water at 85℃; for 0.5h; Inert atmosphere;97.5%
2-iodophenylamine
615-43-0

2-iodophenylamine

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With 18-crown-6 ether; copper; caesium carbonate In 1,2-dichloro-benzene for 24h; Reflux;72.1%
With copper(l) iodide; 2,2'-biimidazole; caesium carbonate In N,N-dimethyl-formamide at 120℃; for 24h; Ullmann reaction; Inert atmosphere;63%
2-bromoaniline
615-36-1

2-bromoaniline

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); acetophenone p-toluenesulfonylhydrazone; lithium tert-butoxide In 1,4-dioxane at 100℃; for 6h; Inert atmosphere;70%
Phenazin
92-82-0

Phenazin

A

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

B

1,2,3,4,6,7,8,9-octahydrophenazine
4006-50-2

1,2,3,4,6,7,8,9-octahydrophenazine

Conditions
ConditionsYield
With Cp*Rh(2-(2-pyridyl)phenyl)H; hydrogen In tetrahydrofuran at 80℃; under 3040.2 Torr; for 48h; Catalytic behavior; Glovebox;A 19%
B 54%
4‑methoxy‑N’‑(1‑phenylethylidene)benzenesulfonohydrazide

4‑methoxy‑N’‑(1‑phenylethylidene)benzenesulfonohydrazide

2-bromoaniline
615-36-1

2-bromoaniline

A

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

B

2-(1-phenylvinyl)aniline
64097-92-3

2-(1-phenylvinyl)aniline

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane at 110℃; Inert atmosphere;A 30%
B 35%
4‑ntro‑N’‑(1‑phenylethylidene)benzenesulfonohydrazide

4‑ntro‑N’‑(1‑phenylethylidene)benzenesulfonohydrazide

2-bromoaniline
615-36-1

2-bromoaniline

A

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

B

2-(1-phenylvinyl)aniline
64097-92-3

2-(1-phenylvinyl)aniline

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane at 110℃; Inert atmosphere;A 35%
B 15%
N'‑(1‑phenylethylidene)benzenesulfonohydrazide
56975-77-0

N'‑(1‑phenylethylidene)benzenesulfonohydrazide

2-bromoaniline
615-36-1

2-bromoaniline

A

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

B

2-(1-phenylvinyl)aniline
64097-92-3

2-(1-phenylvinyl)aniline

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane at 110℃; Inert atmosphere;A 11%
B 30%
acetophenone p-toluenesulfonylhydrazone
4545-21-5

acetophenone p-toluenesulfonylhydrazone

2-bromoaniline
615-36-1

2-bromoaniline

A

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

B

2-(1-phenylvinyl)aniline
64097-92-3

2-(1-phenylvinyl)aniline

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane at 110℃; Inert atmosphere;A 22%
B 28%
bis(2-nitrophenyl)amine
18264-71-6

bis(2-nitrophenyl)amine

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With methanol; sodium
benzene-1,2-diol
120-80-9

benzene-1,2-diol

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

Phenazin
92-82-0

Phenazin

B

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
at 200 - 210℃; im Rohr;
benzene-1,2-diol
120-80-9

benzene-1,2-diol

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Phenazin
92-82-0

Phenazin

hydrogen sulfide
7783-06-4

hydrogen sulfide

ammonia
7664-41-7

ammonia

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Phenazin
92-82-0

Phenazin

Na2S2O4

Na2S2O4

aqueous-alcoholic NaOH-solution

aqueous-alcoholic NaOH-solution

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

pyridine
110-86-1

pyridine

Phenazin
92-82-0

Phenazin

platinum

platinum

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
Hydrogenation;
Phenazin-mono-N-Oxyd
304-81-4

Phenazin-mono-N-Oxyd

ethanol
64-17-5

ethanol

sodium amalgam

sodium amalgam

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

o-nitroiodobenzene
609-73-4

o-nitroiodobenzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3
2: sodium; methanol
View Scheme
2-nitro-aniline
88-74-4

2-nitro-aniline

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3
2: sodium; methanol
View Scheme
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

N1-(2-bromophenyl)benzene-1,2-diamine

N1-(2-bromophenyl)benzene-1,2-diamine

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; caesium carbonate In toluene at 110℃; Inert atmosphere;
N1-(2-chlorophenyl)benzene-1,2-diamine
74864-94-1

N1-(2-chlorophenyl)benzene-1,2-diamine

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; caesium carbonate In toluene at 110℃; Inert atmosphere;
1,2-dichloro-benzene
95-50-1

1,2-dichloro-benzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: caesium carbonate; dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate / toluene / 110 °C / Inert atmosphere
2: caesium carbonate; dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate / toluene / 110 °C / Inert atmosphere
View Scheme
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

1-Bromo-2-iodobenzene
583-55-1

1-Bromo-2-iodobenzene

4-bromo-1,1'-biphenyl
92-66-0

4-bromo-1,1'-biphenyl

5-biphenyl-4-yl-10-(2-bromophenyl)-5,10-dihydro-phenazine

5-biphenyl-4-yl-10-(2-bromophenyl)-5,10-dihydro-phenazine

Conditions
ConditionsYield
Stage #1: 5,10-dihydrophenazine; 4-bromo-1,1'-biphenyl With tris-(dibenzylideneacetone)dipalladium(0); palladium diacetate In toluene for 8h; Reflux;
Stage #2: 1-Bromo-2-iodobenzene In toluene for 8h; Reflux;
97%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

Phenazin
92-82-0

Phenazin

Conditions
ConditionsYield
With oxygen; silver carbonate at 100℃; under 517.162 Torr; for 0.0833333h; Reagent/catalyst; Time;96%
durch Sublimieren;
With ethanol
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

methyl iodide
74-88-4

methyl iodide

fully reduced 5-methylphenazinium
20057-16-3

fully reduced 5-methylphenazinium

Conditions
ConditionsYield
Stage #1: 5,10-dihydrophenazine With potassium tert-butylate In tetrahydrofuran at 20℃; for 1h;
Stage #2: methyl iodide With phosphorus In tetrahydrofuran at 66℃; for 4h;
92%
With n-butyllithium In 1,2-dimethoxyethane; hexane for 0.5h; Ambient temperature; Yield given;
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

2-bromonaphthalene
580-13-2

2-bromonaphthalene

N,N-5,10-di(2-naphthalene)-5,10-dihydrophenazine

N,N-5,10-di(2-naphthalene)-5,10-dihydrophenazine

Conditions
ConditionsYield
With chloro-(2-dicyclohexylphosphino-2′,6′-diisopropoxy-1,1′-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 10h; Sealed tube; Inert atmosphere;90%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

2-bromo-5,10-dihydrophenazine
496269-44-4

2-bromo-5,10-dihydrophenazine

Conditions
ConditionsYield
With N-Bromosuccinimide In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere;89.5%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

terephthaloyl chloride
100-20-9

terephthaloyl chloride

Terephthaloyl-5',5''-bis(5,10-dihydrophenazin)
158670-59-8

Terephthaloyl-5',5''-bis(5,10-dihydrophenazin)

Conditions
ConditionsYield
With dmap In tetrahydrofuran; pyridine at 80℃; for 5h;85%
bromobenzene
108-86-1

bromobenzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

5,10-dihydro-5,10-diphenylphenazine
3665-72-3

5,10-dihydro-5,10-diphenylphenazine

Conditions
ConditionsYield
With tri-tert-butyl phosphine; palladium diacetate; sodium t-butanolate In toluene at 80℃;85%
With chloro(2-dicyclohexylphosphino-2′,6′-di-i-propoxy-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)-palladium(II); sodium t-butanolate; ruphos In 1,4-dioxane at 100℃; for 10h; Buchwald-Hartwig Coupling; Inert atmosphere;0.75 g
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

1-benzyl-4-bromo-benzene
2116-36-1

1-benzyl-4-bromo-benzene

5,10-bis(4-benzylphenyl)-5,10-dihydrophenazine

5,10-bis(4-benzylphenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With tri-tert-butyl phosphine; palladium diacetate; sodium t-butanolate In toluene Reflux;85%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

4-methoxycarbonylphenyl bromide
619-42-1

4-methoxycarbonylphenyl bromide

dimethyl 4,4'-(phenazine-5,10-diyl)dibenzoate

dimethyl 4,4'-(phenazine-5,10-diyl)dibenzoate

Conditions
ConditionsYield
With palladium diacetate; caesium carbonate; XPhos In o-xylene at 130℃; for 12h;85%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

4-N,N-diphenylamino-1-bromobenzene
36809-26-4

4-N,N-diphenylamino-1-bromobenzene

5,10-di-(p-diphenylaminophenyl)-5,10-dihydrophenazine

5,10-di-(p-diphenylaminophenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With tri-tert-butyl phosphine; bis(dibenzylideneacetone)-palladium(0); sodium t-butanolate In o-xylene at 20℃; for 3h;83%
With chloro-(2-dicyclohexylphosphino-2′,6′-diisopropoxy-1,1′-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 12h; Inert atmosphere;20%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

5,10-dihydrophenazine-5-carbamoyl chloride

5,10-dihydrophenazine-5-carbamoyl chloride

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; Reagent/catalyst; Inert atmosphere;83%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

2-chloro-5-bromonitrobenzene
41513-04-6

2-chloro-5-bromonitrobenzene

5,10-bis(4-chloro-2-nitrophenyl)-5,10-dihydrophenazine

5,10-bis(4-chloro-2-nitrophenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With copper; potassium carbonate In 5,5-dimethyl-1,3-cyclohexadiene at 180℃; for 5h; Inert atmosphere;82%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

para-iodoanisole
696-62-8

para-iodoanisole

5,10-bis(4-methoxyphenyl)-5,10-dihydrophenazine

5,10-bis(4-methoxyphenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 12h; Buchwald-Hartwig Coupling; Schlenk technique;82%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

6‐chloro‐5‐nitroquinoline
86984-32-9

6‐chloro‐5‐nitroquinoline

C30H18N6O4

C30H18N6O4

Conditions
ConditionsYield
With copper; potassium carbonate In 5,5-dimethyl-1,3-cyclohexadiene at 180℃; for 5h; Inert atmosphere;81%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

5,10-Dihydrophenazin-5,10-dicarbonsaeure-diethylester

5,10-Dihydrophenazin-5,10-dicarbonsaeure-diethylester

Conditions
ConditionsYield
at 80℃; for 5h;79%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

2-chloroethyl methyl ether
627-42-9

2-chloroethyl methyl ether

5,10-bis(2-methoxyethyl)-5,10-dihydrophenazine

5,10-bis(2-methoxyethyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
Stage #1: 5,10-dihydrophenazine With n-butyllithium In tetrahydrofuran; hexane at 20℃; for 0.5h; Inert atmosphere;
Stage #2: 2-chloroethyl methyl ether In tetrahydrofuran; hexane at 20℃; Inert atmosphere;
78.2%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

1-bromo-4-phenylethynylbenzene
13667-12-4

1-bromo-4-phenylethynylbenzene

5,10-bis(4-(phenylethynyl)phenyl)-5,10-dihydrophenazine

5,10-bis(4-(phenylethynyl)phenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With tri-tert-butyl phosphine; palladium diacetate; sodium t-butanolate In toluene Reflux;78%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

7-bromo-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene

7-bromo-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene

5,10-di(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-5,10-dihydrophenazine

5,10-di(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-5,10-dihydrophenazine

Conditions
ConditionsYield
Stage #1: 5,10-dihydrophenazine; 7-bromo-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene With potassium carbonate In toluene for 0.166667h; Buchwald-Hartwig Coupling; Inert atmosphere;
Stage #2: With tri-tert-butyl phosphine; palladium diacetate In toluene Buchwald-Hartwig Coupling; Reflux; Inert atmosphere;
78%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

methyl chloroformate
79-22-1

methyl chloroformate

5,10-Dihydrophenazin-5,10-dicarbonsaeure-dimethylester
85926-31-4

5,10-Dihydrophenazin-5,10-dicarbonsaeure-dimethylester

Conditions
ConditionsYield
at 80℃; for 5h;77%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

benzene-1,3-dicarbonyl dichloride
99-63-8

benzene-1,3-dicarbonyl dichloride

Isophthaloyl-5',5''-bis(5,10-dihydrophenazin)
158670-60-1

Isophthaloyl-5',5''-bis(5,10-dihydrophenazin)

Conditions
ConditionsYield
With dmap In tetrahydrofuran; pyridine at 80℃; for 5h;77%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

7-bromo-2,12-di-tert-butyl-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene

7-bromo-2,12-di-tert-butyl-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene

5,10-bis(2,12-di-tert-butyl-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-5,10-dihydrophenazine

5,10-bis(2,12-di-tert-butyl-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-5,10-dihydrophenazine

Conditions
ConditionsYield
Stage #1: 5,10-dihydrophenazine; 7-bromo-2,12-di-tert-butyl-5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene With potassium carbonate In toluene for 0.166667h; Buchwald-Hartwig Coupling; Inert atmosphere;
Stage #2: With tri-tert-butyl phosphine; palladium diacetate In toluene for 20h; Buchwald-Hartwig Coupling; Reflux; Inert atmosphere;
75%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

phenyl chloroformate
1885-14-9

phenyl chloroformate

5,10-Dihydrophenazin-5,10-dicarbonsaeure-diphenylester
158670-54-3

5,10-Dihydrophenazin-5,10-dicarbonsaeure-diphenylester

Conditions
ConditionsYield
With dmap In pyridine for 3h; Heating;74%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

p-trifluoromethylphenyl bromide
402-43-7

p-trifluoromethylphenyl bromide

5,10-bis(4-(trifluoromethyl)phenyl)-5,10-dihydrophenazine

5,10-bis(4-(trifluoromethyl)phenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 12h; Buchwald-Hartwig Coupling; Schlenk technique;73%
With chloro(2-dicyclohexylphosphino-2′,6′-di-i-propoxy-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)-palladium(II); sodium t-butanolate; ruphos In 1,4-dioxane at 100℃; for 10h; Buchwald-Hartwig Coupling; Inert atmosphere;0.96 g
With chloro-(2-dicyclohexylphosphino-2′,6′-diisopropoxy-1,1′-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 10h; Inert atmosphere; Sealed tube;
1-bromo-4-methoxy-benzene
104-92-7

1-bromo-4-methoxy-benzene

5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

5,10-bis(4-methoxyphenyl)-5,10-dihydrophenazine

5,10-bis(4-methoxyphenyl)-5,10-dihydrophenazine

Conditions
ConditionsYield
With chloro-(2-dicyclohexylphosphino-2’,6’-diisopropoxy-1,1‘-biphenyl)[2-(2-aminoethyl)phenyl] palladium(ll) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 16h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;73%
With chloro-(2-dicyclohexylphosphino-2’,6’-diisopropoxy-1,1‘-biphenyl)[2-(2-aminoethyl)phenyl] palladium(ll) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 10h; Inert atmosphere; Sealed tube;46%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

2-bromo-4,6-diphenyl-1,3,5-triazabenzene
80984-79-8

2-bromo-4,6-diphenyl-1,3,5-triazabenzene

5-(3,5-diphenyltriazine 2-yl)-10H-dihydrophenazine

5-(3,5-diphenyltriazine 2-yl)-10H-dihydrophenazine

Conditions
ConditionsYield
With copper; sodium t-butanolate In toluene for 24h; Inert atmosphere; Reflux;71%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

iodobenzene
591-50-4

iodobenzene

5-phenyl-5,10-dihydro-phenazine
49662-17-1

5-phenyl-5,10-dihydro-phenazine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); tri-tert-butyl phosphine; sodium t-butanolate In toluene at 115℃; for 12h; Inert atmosphere;70.9%
5,10-dihydrophenazine
613-32-1

5,10-dihydrophenazine

iodobenzene
591-50-4

iodobenzene

5,10-dihydro-5,10-diphenylphenazine
3665-72-3

5,10-dihydro-5,10-diphenylphenazine

Conditions
ConditionsYield
With chloro-(2-dicyclohexylphosphino-2′,6′-diisopropoxy-1,1′-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II) methyl-tert-butyl ether adduct; sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 10h; Inert atmosphere; Sealed tube;69%
With sodium t-butanolate; ruphos In 1,4-dioxane at 110℃; for 12h; Buchwald-Hartwig Coupling; Schlenk technique;25%

613-32-1Relevant articles and documents

NIR organic dyes based on phenazine-cyanine for photoacoustic imaging-guided photothermal therapy

Yan, Yongchao,Chen, Jiawen,Yang, Zhijuan,Zhang, Xiao,Liu, Zhuang,Hua, Jianli

, p. 7420 - 7426 (2018)

As non-invasive diagnosis and therapy methods, photoacoustic (PA) imaging and photothermal therapy (PTT) have attracted extensive attention. Herein, two new acceptor-donor-acceptor near-infrared organic phenazine-cyanine dyes PH-1 and PH-2 were reported for photoacoustic imaging-guided photodynamic therapy. In the strong donor phenazine molecule, the electron-withdrawing indole salt unit was introduced for absorption to the near-infrared region. To improve water solubility, the two organic dyes were assembled with human serum albumin (HSA) to form nanoparticles of appropriate sizes, i.e., PH-1@HSA and PH-2@HSA, which showed excellent stability in both weakly acidic and weakly basic environments. Moreover, the results showed that PH-1@HSA and PH-2@HSA nanoparticles can effectively transform luminous energy to thermal energy in vitro and in vivo, and they can be utilized for PA imaging. Importantly, PH-1@HSA can accumulate in mice subcutaneous tumors by enhanced permeability and retention (EPR) and damage cancer tissues effectively.

Highly efficient green organic light emitting diodes with phenanthroimidazole-based thermally activated delayed fluorescence emitters

Huang, Zhi,Xiang, Songpo,Zhang, Qing,Lv, Xialei,Ye, Shaofeng,Guo, Runda,Wang, Lei

, p. 2379 - 2386 (2018)

Here, a phenanthroimidazole moiety was firstly introduced into the construction of thermally activated delayed fluorescence (TADF) emitters, and two novel TADF emitters consisting of phenanthroimidazole as the acceptor group and phenazine as the donor group, 1-(4-(tert-butyl)phenyl)-2-(4-(10-phenylphenazin-5(10H)-yl)phenyl)-1H-phenanthro[9,10-d]imidazole (PPZTPI) and 1-phenyl-2-(4-(10-phenylphenazin-5(10H)-yl)phenyl)-1H-phenanthro[9,10-d]imidazole (PPZPPI) were designed and synthesized. The highly twisted conformation between phenazine and phenanthroimidazole in the molecules results in effective spatial separation of the HOMO and LUMO and small singlet-triplet splittings. Both compounds possess obvious TADF features. Their crystallographic properties, electronic structures, thermal stabilities, photophysical properties, and energy levels are studied systematically. Organic light-emitting diodes (OLEDs) using these two green TADF emitters demonstrate high external quantum efficiencies of 21.06% for PPZPPI and 20.52% for PPZTPI, respectively, which is comparable to most of the previously reported TADF OLEDs.

Singlet and Triplet Contributions to the Excited-State Activities of Dihydrophenazine, Phenoxazine, and Phenothiazine Organocatalysts Used in Atom Transfer Radical Polymerization

Bhattacherjee, Aditi,Sneha, Mahima,Lewis-Borrell, Luke,Amoruso, Giordano,Oliver, Thomas A.A.,Tyler, Jasper,Clark, Ian P.,Orr-Ewing, Andrew J.

, p. 3613 - 3627 (2021)

The photochemical dynamics of three classes of organic photoredox catalysts employed in organocatalyzed atom-transfer radical polymerization (O-ATRP) are studied using time-resolved optical transient absorption and fluorescence spectroscopy. The nine catalysts selected for study are examples of N-aryl and core-substituted dihydrophenazine, phenoxazine and phenothiazine compounds with varying propensities for control of polymerization outcomes. Excited singlet-state lifetimes extracted from the spectroscopic measurements are reported in N,N-dimethylformamide (DMF), dichloromethane (DCM), and toluene. Ultrafast (200 fs to 3 ps) electronic relaxation of the photocatalysts after photoexcitation at near-UV wavelengths (318-390 nm) populates the first singlet excited state (S1). The S1-state lifetimes range from 130 ps to 40 ns with a considerable dependence on the photocatalyst structure and the solvent. The competition between ground electronic state recovery and intersystem crossing controls triplet state populations and is a minor pathway in the dihydrophenazine derivatives but is of greater importance for phenoxazine and phenothiazine catalysts. A comparison of our results with previously reported O-ATRP performances of the various photoredox catalysts shows that high triplet-state quantum yields are not a prerequisite for controlling polymer dispersity. For example, the photocatalyst 5,10-bis(4-cyanophenyl)-5,10-dihydrophenazine, shown previously to exert good polymerization control, possesses the shortest S1-state lifetime (135 ps in DMF and 180 ps in N,N-dimethylacetamide) among the nine examples reported here and a negligible triplet-state quantum yield. The results call for a re-evaluation of the excited-state properties of most significance in governing the photocatalytic behavior of organic photoredox catalysts in O-ATRP reactions.

Formation of 5,10-dihydrophenazine from phenazine by Pseudomonas cepacia IFO 15124 at low oxygen tensions

Kawashima, Hideki,Ogawa, Satoshi

, p. 1186 - 1187 (1996)

5,10-Dihydrophenazine (H2Phen) was formed from phenazine (Phen) by Pseudomonas cepacia IFO 15124 in growing cultures at low oxygen tensions. Effects of culture conditions on microbial reduction of Phen with this strain were investigated. Under optimized conditions, the transformation of Phen to H2Phen by this strain gave the molar conversion yield of 30%. However, H2Phen was not detected in the culture medium when the strain was incubated with Phen with sufficient aeration.

Cross-linking Effects on Performance Metrics of Phenazine-Based Polymer Cathodes

Gannett, Cara N.,Peterson, Brian M.,Shen, Luxi,Seok, Jeesoo,Fors, Brett P.,Abru?a, Héctor D.

, p. 2428 - 2435 (2020)

Developing cathodes that can support high charge–discharge rates would improve the power density of lithium-ion batteries. Herein, the development of high-power cathodes without sacrificing energy density is reported. N,N′-diphenylphenazine was identified as a promising charge-storage center by electrochemical studies due to its reversible, fast electron transfer at high potentials. By incorporating the phenazine redox units in a cross-linked network, a high-capacity (223 mA h g?1), high-voltage (3.45 V vs. Li/Li+) cathode material was achieved. Optimized cross-linked materials are able to deliver reversible capacities as high as 220 mA h g?1 at 120 C with minimal degradation over 1000 cycles. The work presented herein highlights the fast ionic transport and rate capabilities of amorphous organic materials and demonstrates their potential as materials with high energy and power density for next-generation electrical energy-storage technologies.

A robust phenazine-containing organic polymer as catalyst for amine oxidative coupling reactions

Guo, Zhiyong,Lin, Junyu,Zhan, Hongbing

, p. 338 - 344 (2020)

Here we present the design and synthesis of a new robust microporous organic polymer (TPBP) decorated with phenazine groups which endowed reversibly redox-active properties. The obtained TPBP possesses relatively high surface area (359 m2/g) and good thermal stability. TPBP exhibits excellent catalytic capability for the oxidative homocoupling of amines with high activity and selectivity toward target products. Besides, this metal-free catalyst demonstrated excellent recyclability after 6 cycles under the investigated conditions. By means of EPR and UV-vis spectroscopy, a plausible mechanism of the amine oxidative coupling reaction was deduced via a single electron transfer from TPBP radical cations to amine substrates.

Dihydrophenazine linked porous organic polymers for high capacitance and energy density pseudocapacitive electrodes and devices

Zhang, Huanhuan,Tang, Xiaohui,Gu, Cheng

, p. 4984 - 4989 (2021)

Redox porous organic polymers are promising pseudocapacitive materials. However, their specific capacitance still needs further elevation. Herein, we report a novel dihydrophenazine derived porous organic polymer, GT-POP-1. The GT-POP-1 based electrode and asymmetric device show high specific capacitance and energy density metrics of 97.1 mF cm?2and 7.3 μW h cm?2

Controlled emission colors and singlet-triplet energy gaps of dihydrophenazine-based thermally activated delayed fluorescence emitters

Lee, Jiyoung,Shizu, Katsuyuki,Tanaka, Hiroyuki,Nakanotani, Hajime,Yasuda, Takuma,Kaji, Hironori,Adachi, Chihaya

, p. 2175 - 2181 (2015)

We have developed thermally activated delayed fluorescence (TADF) emitters containing 5,10-dihydrophenazine as an electron donor and various electron-acceptor units. The TADF emitters exhibit wide ranges of emission colors from green to orange, singlet-triplet energy gaps ΔEST of ~0-0.19 eV, and delayed fluorescence lifetimes τd of 0.1-50 μs. An organic light-emitting diode containing one of the TADF emitters exhibits a maximum external quantum efficiency (EQE) of 12%, which is higher than those obtained with conventional fluorescent emitters. Time-resolved photoluminescence measurements of the compounds in a host matrix reveal that TADF makes a large contribution to the EQE of the devices. Our findings provide guidelines for modulating ΔEST and τd of TADF emitters.

Dihydrophenazine-based double-anchoring dye for dye-sensitized solar cells

Kumar, Dhirendra,Chen, Yu-Lin,Tsai, Chih-Hung,Wong, Ken-Tsung

, p. 361 - 369 (2020)

A novel dihydrophenazine-based organic di-anchoring dye DK-11 was synthesized by utilizing a simple synthetic protocol. The dye was characterized by optical and electrochemical studies and used as a sensitizer for dye-sensitized solar cell. The proposed butterfly structure was supported by IR experiments which ensured the binding of both carboxylic acid units on the semiconductor surface. Using the dye DK-11, the device generated an efficiency of 5.07% with JSC, VOC, and FF values of 10.65 mA/cm2, 0.67 V, and 0.71, respectively.

Post-Synthetic Modification of Metal-Organic Frameworks Bearing Phenazine Radical Cations for aza-Diels-Alder Reactions

Jiang, Wei-Ling,Huang, Bin,Wu, Meng-Xiang,Zhu, Ye-Kai,Zhao, Xiao-Li,Shi, Xueliang,Yang, Hai-Bo

supporting information, p. 3985 - 3992 (2021/11/01)

Metal-organic frameworks (MOFs) consisting of organic radicals are of great interest because they have exhibited unique and intriguing optical, electronic, magnetic, and chemo-catalytic properties, and thus have demonstrated great potential applications in optical, electronic, and magnetic devices, and as catalysts. However, the preparation of MOFs bearing stable organic radicals is very challenging because most organic radicals are highly reactive and difficult to incorporate into the framework of MOFs. Herein we reported a post-synthetic modification strategy to prepare a novel MOF containing phenazine radical cations, which was used as heterogeneous catalyst for aza-Diels-Alder reaction. The zinc-based metal-organic framework Zn2(PHZ)2(dabco) (N) was successfully synthesized from 5,10-di(4-benzoic acid)-5,10-dihydrophenazine (PHZ), triethylene diamine (dabco) with Zn(NO3)2 ? 6H2O by solvothermal method. The as-synthesized MOF N was partially oxidized by AgSbF6 to form MOF R containing ~10% phenazine radical cation species. The resultant MOF R was found to keep the original crystal type of N and very persistent under ambient conditions. Consequently, MOF R was successfully employed in radical cation-catalyzed aza-Diels-Alder reactions with various imine substrates at room temperature with high reaction conversion. Moreover, heterogeneous catalyst MOF R was reusable up to five times without much loss of catalytic activity, demonstrating its excellent stability and recyclability. Therefore, the post-synthetic modification developed in this work is expected to become a versatile strategy to prepare radical-based MOFs for the application of heterogeneous catalysts in organic synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 613-32-1